Risk Factors for the Development of Hyaline Membrane Disease in Preterm Infants
Abstract
Hyaline membrane disease (HMO) is a respiratory disease commonly found in preterm infants. While this disease occurs as the result of surfactant deficiency which is a function of gestational age, certain maternal and neonatal factors play a role in the development of the disorder. Preterm infants born at the Department of Obstetrics and Gynecology, Cipto Mangunkusumo Hospital, Jakarta, between, March 1997 and May 1998 were studied for the development of HMO. It was concluded that antepartum hemorrhage, gestational age, sex, mod of birth, and the first minute Apgar score were associated with the development of HMD, while the use of contraceptives, early rupture of the membrane, maternal morbidity, and passive cigarette smoking were not.
References
Perelman RH, Farrel PM. Analysis of causes of neonatal death in the United States with specific emphasis on fatal hyaline membrane disease. Pediatrics 1982; 70:570-5.
Korones SB, Bada-Ellzey HS. Neonatal decision making. St Louis: BC Decker; 1993. p. 206.
Robertson B. New targets for surfactant replacement therapy: experimental and clinical aspects. Arch Dis Child Fetal Neonatal 1996; 75:F1-3.
Piper JM, Langer O. Does maternal diabetes delay fetal pulmonary maturity? Am J Obstet Gynecol 1993; 168:783-6.
Robert MF, Neff RK, Hubbell JP, Taeusch HW, Avery ME. Association between maternal diabetes and the respiratory distress syndrome in the newborn. N Engl J Med 1976; 294:357-60.
Roberton NRC. A manual of neonatal intensive care. London: Edward Arnold; 1993.
Hulsey TC, Alexander GR, Robillard PY, Annibals DJ, Keenan A. Hyaline membrane disease: the role of ethnicity and maternal risk characteristics. Am J Obstet Gynecol 1993;169:572-6.
Cooper PA, Simchowitz ID, Sandler DL, Rothberg AD, Davies VA, Wainer S. Prevalence of hyaline membrane disease in black and white infants. S Afr Med J 1994; 84:23-5 [Abstr].
Hsieh FY. Sample size tables for logistic regression. Biometrics 1988; 8:195-8.
Wariyar U, Tin W, Hey E. Gestational assessment assessed. Arch Dis Child Fetal Neonatal1997;77: F216-20.
Dubowitz L, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr 1970; 17:19-25.
van den Berg GJ, Oechsli FW. Prematurity. In: Bracken MB, ed. Perinatal epidemiology. New York: Oxford University Press; 1984. p. 69-85.
Sastroasmoro S, Nurhamzah W, Madiyono B, Oesman IN, Putra ST. Association between maternal hormone exposure and development of congenital heart disease of the conotruncal type- a case control study. Pediatr Indones 1993; 33:291-300.
Bearer CF. Occupational and environmental risk factors. In: Fanaroff AA, Martin RJ, eds. Neonatal-perinatal medicine. St. Louis: Mosby; 1977. p. 188-202.
Martin RJ, Fanaroff AA. The respiratory distress syndrome and its management. In: Fanaroff AA, Martin RJ, eds. Neonatal-perinatal medicine. Diseases of the fetus and infant. 6th ed. St. Louis: Mosby; 1997. p. 1018-27.
Cosmi EV, Scarpelli EM. Pulmonary surfactant system. Amsterdam: Elsevier, 1983.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Accepted 2017-07-10
Published 2017-07-11
